Dipyridamole echocardiography stress testing in hypertensive patients. Targets and tools

Area of Science:

• Cardiology
• Hypertension Research
• Diagnostic Imaging

Background:

• Arterial hypertension can reduce coronary flow reserve through multiple pathways, including coronary artery disease, left ventricular hypertrophy, and microvascular dysfunction.
• Effective diagnosis requires distinct markers tailored to each of these hypertensive targets.
• Understanding these mechanisms is crucial for managing cardiovascular risk in hypertensive patients.

Purpose of the Study:

• To investigate the utility of specific diagnostic markers in differentiating the mechanisms of reduced coronary flow reserve in arterial hypertension.
• To evaluate the reliability of two-dimensional echocardiography and electrocardiography during dipyridamole infusion in hypertensive individuals.

Main Methods:

• Utilized two-dimensional echocardiography during dipyridamole infusion to assess transient dyssynergy as a marker of coronary artery disease.
• Analyzed dipyridamole-induced ST segment depression in relation to angiographically assessed coronary disease, left ventricular hypertrophy, and microvascular disease.
• Correlated electrocardiographic findings with echocardiographic assessments and coronary flow reserve measurements during pacing.

Main Results:

• Transient dyssynergy on echocardiography reliably identifies coronary artery disease in both normotensive and hypertensive patients.
• Dipyridamole-induced ST segment depression in hypertensive patients often occurs without significant coronary artery disease and can be linked to left ventricular hypertrophy.
• ST segment depression, even with normal left ventricular mass, correlates with impaired coronary flow reserve, suggesting microvascular disease.

Conclusions:

• Echocardiography effectively detects coronary artery disease in hypertensive individuals.
• Electrocardiographic changes during dipyridamole testing in hypertension may indicate left ventricular hypertrophy or microvascular disease, even in the absence of obstructive coronary artery disease.
• The clinical significance of echocardiographically silent electrocardiographic changes in hypertension requires further investigation to determine their role as markers of early myocardial damage.